UTSWTxID

More pearls from @masumi_ueda @fredhutch on Stem Cell Procurement, Conditioning Regimen, and TBI!

Today, you are in for a treat @masumi_ueda @fredhutch is presenting Allogeneic Hematopoietic Cell Transplantation at our Transplant Infectious Diseases Lecture Series! We are so lucky!

An amazing tag-team presentation on cutting edge management of AML and ALL from @madanatyazan and @VIrizarryGatell for our Transplant ID lecture series! @RicardoLaHozMD @chrislarsenmd @VBeechar @Hanineelhaddad

Good morning #TXID! @RicardoLaHozMD continues our Transplant ID lecture series with an illuminating talk on Donor Derived Infections and the challenges of donor call!

Today, in our #TxID lecture Series, we have @Hanineelhaddad. She is dropping important pearls on the management of the hematologic stem cell transplant and CAR-T recipient. We are soooo lucky! @chrislarsenmd @BradCutrellMD @UTSWInfDis @EmilyWongID

We’re thrilled to introduce @EmilyWongID , our #TxID Fellow, for the 2024-2025 Academic Year! Give her a follow! @chrislarsenmd @RicardoLaHozMD @BradCutrellMD @TxID_Fellows @AST_IDCOP @MaryjaneFarrMD

Today our Associate Program Director @chrislarsenmd is celebrating his birthday! 🎂 Say hi to him! @AST_IDCOP

Superstar @VBeechar is joining our program! He is presenting - Evaluating Real World Experience Using Maribavir for R/R CMV in Kidney Transplant Recipients @AST_IDCOP

Bookmark this one! Outstanding talk by @monicaslavin @AST_IDCOP

There is a a potential association between Check Point Inhibitors and rejection in SOT in the available preliminary data?@AST_IDCOP

Oncogenic viruses associated with malignancy in SOT @AST_IDCOP

Next Up @monicaslavin - Addressing unique infections risks with specific cancer chemo therapies in SOT with malignancy!

Include Immune Mimickers in patients on Checkpoint Inhibitors @AST_IDCOP @TxID_Fellows

How Do You Handle Infection in the Immunocompromised Transplant Patient Who Becomes Even More Immunocompromised? @ArunaSubraman12 providing pearls on JAK inhibitors @AST_IDCOP

Run to Level 1 ABC 118 Respiratory Viruses in Transplantation: What Every Transplant Provider Needs to Know - Staring Now @AST_IDCOP

The @UTSWNews @UTSWTxID team, lead by Dr. Vidya Jagadeesan, is here to take care of business! #TIDSheros Vidya Jagadeesan, Stella Radostra, @EmilyLundburg , @meganbostonpa @cristina_kochi

1/9 Our first Tweetorial! At the time of organ offer, transplant teams and the intended recipient must consider multiple concepts and variables. The first concept is the most important. Transplantation has inherent risks, and donor-derived disease is one of them.